Group structure
3 companies in 1 country
United States1
Headquarters not stated2
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine of every company in the group, current ones first.
22 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETAMINOPHEN, ASPIRIN AND CAFFEINE250mg; 250mg; 65mg · Tablet | Paracetamol, Acetylsalicylic acid, Caffeine | United States | Marketed | 2001 |
| ACETAMINOPHEN EXTRA STRENGTH RAPID RELEASE TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN EXTRA STRENGTH RED TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN EXTRA STRENGTH TABLETS500 mg · Tablet | Paracetamol | Canada | Marketed | 2025 |
| ACETAMINOPHEN REGULAR325 mg · Tablet | Paracetamol | Canada | Authorised | |
| AMPHETAMINE SULFATE10MG | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Amfetamine | United States | Marketed | 1984 |
| ARTHRITIS PAIN RELIEF650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Marketed | 2022 |
| BUTALBITAL AND ACETAMINOPHEN300mg; 50mg · Capsule | Paracetamol, Butalbital | United States | Marketed | 2017 |
| GABAPENTIN CAPSULES400 mg · Capsule | Gabapentin | Canada | Authorised | |
| GABAPENTIN CAPSULES300 mg · Capsule | Gabapentin | Canada | Authorised | |
| GABAPENTIN CAPSULES100 mg · Capsule | Gabapentin | Canada | Authorised | |
| GUAIFENESIN AND PSEUDOEPHEDRINE HYDROCHLORIDE1.2gm; 120mg | 600mg; 60mg · Tablet, extended release | Guaifenesin, Pseudoephedrine | United States | Marketed | 2015 |
| IBUPROFEN100mg | 200mg | 300mg | 400mg | 600mg | 800mg · Tablet | Ibuprofen | United States | Marketed | 1985 |
| METFORMIN TABLETS850 mg · Tablet | Metformin | Canada | Marketed | 2022 |
| METFORMIN TABLETS500 mg · Tablet | Metformin | Canada | Marketed | 2022 |
| MUSCLE & BODY650 mg · Tablet (Extended-Release) | Paracetamol | Canada | Marketed | 2025 |
| PENICILLAMINE250mg · Capsule | Penicillamine | United States | Marketed | 2019 |
| SILDENAFIL CITRATE10mg base/ml · For suspension | Sildenafil | United States | Marketed | 2019 |
| VIGABATRIN500mg/packet · For solution | Vigabatrin | United States | Marketed | 2017 |
| ZONISAMIDE100mg | 25mg | 50mg · Capsule | Zonisamide | United States | Marketed | 2005 |
| AMPHETAMINE10mg | 15mg | 20mg · Tablet, extended release | Amfetamine | United States | tentative | 2026 |
| AMPHETAMINE12.5mg | 15.7mg | 18.8mg | 3.1mg | 6.3mg | 9.4mg · Tablet, orally disintegrating | Amfetamine | United States | tentative | 2025 |